Literature DB >> 27825482

Unraveling genomic and phenotypic nature of multidrug-resistant (MDR) Pseudomonas aeruginosa VRFPA04 isolated from keratitis patient.

Murugan N1, Malathi J2, Umashankar V3, Madhavan H N4.   

Abstract

Multidrug-resistant (MDR) Pseudomonas aeruginosa VRFPA04, obtained from a keratitis patient was found to exhibit resistance to betalactam (Penicillins, cephalosporins, including carbapenems, except aztreonam), aminoglycosides, quinolone group of drugs and susceptible to colistin. The complete genome sequencing of the ocular isolate to measure and ascertain the degree of multidrug resistance in VRFPA04 strain resulted in 6,818,030bp (6.8Mb) genome sizes, which happen to be the third largest genome available in the Genbank to date. Two chromosomally integrated class I integrons carrying blaVIM-2 carbapenemase gene, multiple secretory systems consisting of types I-VI and VIII proteins and ocular virulence factors exo-T, Y, U and exotoxin A, a gene that inhibits protein synthesis which could have caused corneal cell death and Phytohormone auxin biosynthetic protein were detected in the genome of VRFPA04 Genome. In addition, 58 Regions of Genomic Plasticity (RGPs) regions, multiple phage genomes, genomic islands, CRISPR genes and RND family efflux pumps, such as MexCD-OprJ and MexEF-OprN and its regulators, MexT and MexR, were unraveled in VRFPA04. Thus, the current study reveals the virulence factors and resistome nature of an ocular isolate P aeruginosa VRFPA04 genome.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Aminoglycoside resistance; Genomics; Integron; Metallo β-lactamase; Multidrug resistance; Prophages; Pseudomonas aeruginosa; β-lactamase

Mesh:

Substances:

Year:  2016        PMID: 27825482     DOI: 10.1016/j.micres.2016.10.002

Source DB:  PubMed          Journal:  Microbiol Res        ISSN: 0944-5013            Impact factor:   5.415


  9 in total

1.  Mutational analyses of regulatory genes, mexR, nalC, nalD and mexZ of mexAB-oprM and mexXY operons, in efflux pump hyperexpressing multidrug-resistant clinical isolates of Pseudomonas aeruginosa.

Authors:  Manju Suresh; N Nithya; P R Jayasree; K P Vimal; P R Manish Kumar
Journal:  World J Microbiol Biotechnol       Date:  2018-05-30       Impact factor: 3.312

2.  Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis.

Authors:  Sandamali A Ekanayaka; Sharon A McClellan; Ronald P Barrett; Linda D Hazlett
Journal:  J Ocul Pharmacol Ther       Date:  2017-12-13       Impact factor: 2.671

3.  Genomic Surveillance of Clinical Pseudomonas aeruginosa Isolates Reveals an Additive Effect of Carbapenemase Production on Carbapenem Resistance.

Authors:  Luke Diorio-Toth; Sidra Irum; Robert F Potter; Meghan A Wallace; Muhammad Arslan; Tehmina Munir; Saadia Andleeb; Carey-Ann D Burnham; Gautam Dantas
Journal:  Microbiol Spectr       Date:  2022-05-31

4.  Virulence genome analysis of Pseudomonas aeruginosa VRFPA10 recovered from patient with scleritis.

Authors:  Nandagopal Murugan; Jambulingam Malathi; Vetrivel Umashankar; Hajib Narahari Rao Madhavan
Journal:  Genom Data       Date:  2017-02-06

5.  Accessory genome of the multi-drug resistant ocular isolate of Pseudomonas aeruginosa PA34.

Authors:  Dinesh Subedi; Gurjeet Singh Kohli; Ajay Kumar Vijay; Mark Willcox; Scott A Rice
Journal:  PLoS One       Date:  2019-04-15       Impact factor: 3.240

6.  A Core Genome Multilocus Sequence Typing Scheme for Pseudomonas aeruginosa.

Authors:  Romário Oliveira de Sales; Letícia Busato Migliorini; Renato Puga; Bela Kocsis; Patricia Severino
Journal:  Front Microbiol       Date:  2020-05-26       Impact factor: 5.640

7.  Genetic Diversity, Distribution, and Genomic Characterization of Antibiotic Resistance and Virulence of Clinical Pseudomonas aeruginosa Strains in Kenya.

Authors:  Shahiid Kiyaga; Cecilia Kyany'a; Angela W Muraya; Hunter J Smith; Emma G Mills; Caleb Kibet; Gerald Mboowa; Lillian Musila
Journal:  Front Microbiol       Date:  2022-03-14       Impact factor: 5.640

8.  Comparative genomics of clinical strains of Pseudomonas aeruginosa strains isolated from different geographic sites.

Authors:  Dinesh Subedi; Ajay Kumar Vijay; Gurjeet Singh Kohli; Scott A Rice; Mark Willcox
Journal:  Sci Rep       Date:  2018-10-23       Impact factor: 4.379

9.  Antibiotic Resistance Characteristics of Pseudomonas aeruginosa Isolated from Keratitis in Australia and India.

Authors:  Mahjabeen Khan; Fiona Stapleton; Stephen Summers; Scott A Rice; Mark D P Willcox
Journal:  Antibiotics (Basel)       Date:  2020-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.